Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 9/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 9/20 | 0.47 |
| ▸ | F2R | P25116 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 3/20 | 0.42 |
| ▸ | ACHE | P22303 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7843159 | 0.95 | ITGB3 (0.46) | ITGB3ITGA2BF2RNPC1APOBEC3A | |
| SCHEMBL7501795 | 0.91 | ITGB3 (0.54) | ITGB3ITGA2BF2RNPC1RAB9A | |
| SCHEMBL7500231 | 0.89 | ITGB3 (0.45) | ITGB3ITGA2BF2RNPC1RAB9A | |
| SCHEMBL7492120 | 0.88 | ITGB3 (0.47) | ITGB3ITGA2BF2RNPC1RAB9A | |
| Hydrochloric Acid SCHEMBL7507317 | 0.88 | ITGB3 (0.59) | ITGB3ITGA2BF2R | |
| SCHEMBL7498497 | 0.87 | ITGB3 (0.48) | ITGB3ITGA2BF2RRAB9APKM | |
| SCHEMBL7496753 | 0.86 | ITGB3 (0.56) | ITGB3ITGA2BF2R | |
| SCHEMBL7440093 | 0.85 | KDM4E (0.56) | ITGB3ITGA2BF2RKDM4EPKM | |
| SCHEMBL7843158 | 0.84 | ITGB3 (0.49) | ITGB3ITGA2BF2RBCHEACHE | |
| SCHEMBL7504289 | 0.84 | ITGB3 (0.52) | ITGB3ITGA2BF2RNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380215-B1 | FOR PREVENTION AND/OR TREATMENT OF DISEASES CAUSED BY THROMBUS FORMATION SUCH AS ARTERIAL THROMBOSIS, ARTERIAL SCLEROSIS, ISCHEMIC HEART DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD (JP) | 2002-04-30 | — | — | US | disclosed |
| EP-1106606-A2 | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-13 | — | — | EP | disclosed |